RecruitingNCT06342284

Patient-Generated Health Data Collection During Chemoradiotherapy for Lung Cancer

Patient-Generated Health Data Collection During Chemoradiotherapy for Lung Cancer: A Pilot Study

Sponsor

The New York Proton Center

Enrollment

40 participants

Start Date

Mar 22, 2024

Study Type

OBSERVATIONAL

Conditions

Thoracic Cancer

Summary

This is an observational study involving the collection of patient-generated health data using an Apple Watch, a home pulse oximeter, and a smartphone during a course of proton beam radiotherapy for lung cancer. The study period over which this information is collected will range from the day of study enrollment until two weeks after radiotherapy completion. Subjects will complete a short satisfaction survey at the end of the study period. Other information that is collected as part of routine care for this patient population will be extracted from subjects' medical records during the study period and afterwards.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study collects health data from wearable devices (like fitness trackers and smartphones) during radiation therapy for lung cancer, to better understand how patients feel day-to-day and to detect treatment side effects earlier. **You may be eligible if...** - You are 18 or older with lung cancer (any type) - You are scheduled for at least 15 sessions of proton beam radiation therapy to the chest area - You can complete surveys in English or Spanish - You are willing to wear the devices provided by the study team **You may NOT be eligible if...** - You are being treated for another active cancer that would affect side effects from chest radiation - You are pregnant or unable to use contraception (if applicable) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.